ARCHIVES

NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available

This article is from The Cancer Letter archive.

Vol. 10 No. 38 | October 5, 1984

Download PDF Visit The Full Archive

Related Articles

Community Cancer Control Program Survives Schmidt Criticism; NCAB Votes To Continue

October 17, 1975

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

NCAB Subcommittee Approves Compromise On Changes In Organ Site Program

April 9, 1982

NCI, USSR Agree On New Collaborative Cancer Control Studies

June 20, 1975

NCI To Conduct Survey On Needs For Compliance with Biohazard Requirements

December 16, 1977

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001